View Full Paper

Owner Consent Verified
Report 4.9

Pharmacovigilance Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe

20
Pages
MLA
Style
~ 21–31 mins
Reading Time
AIOps Open Banking Sustainability
Abstract

This report investigates “Pharmacovigilance Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe” using a survey-based structural equation modeling. Through a human-centered lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Download PDF Order Similar Paper Save

Pharmacovigilance Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe

ABSTRACT
Pharmacovigilance Adoption in Pharmaceutical Firms: Governance And Risk — Evidence from Europe is unpacked across themes: scalability, costs, benefits, and ethics. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
15 Pages 4.3
Human Factors And Usability in Robotic Process Automation for SMEs in Sub-Saharan Africa: Post-Pandemic Lessons
Psychology FinTech Sustainability
View Paper
25 Pages 4.8
5G Networks Adoption in Public Sector Agencies in the UK: Change Management — A Comparative Perspective
Energy RPA Tourism
View Paper
21 Pages 4.9
Workforce Analytics for Logistics Hubs in Europe: Data Quality And Bias | Evidence from Middle East
RPA Energy Sociology
View Paper